Navigation Links
FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
Date:12/30/2011

BEDMINSTER, N.J., Dec. 30, 2011 /PRNewswire/ -- ProStrakan, Inc., a subsidiary of Kyowa Hakko Kirin Co. Ltd. (KHK), and an international specialty pharmaceutical company, today announces that the U.S. Food and Drug Administration (FDA) has approved the TIRF (Transmucosal Immediate Release Fentanyl) REMS (Risk Evaluation and Mitigation Strategy) Access program. This new REMS is a single shared system for all TIRF products, including ABSTRAL® (fentanyl) sublingual tablets, an opioid analgesic used in the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.

The goals of the TIRF REMS Access program are to mitigate the risk of misuse, abuse, addiction, overdose and serious complications due to medication errors by:

  • Prescribing and dispensing TIRF medicines only to appropriate patients, which includes use only in opioid-tolerant patients.
  • Preventing inappropriate conversion between fentanyl products.
  • Preventing accidental exposure to children and others for whom it was not prescribed.
  • Educating prescribers, pharmacists and patients on the potential for misuse, abuse, addiction and overdose of TIRF medicines.

TIRF products are available only through REMS programs, which require enrollment by prescribers, their patients, pharmacies and distributors. Today, TIRF manufacturers have separate REMS programs and a health care provider and pharmacy must enroll in multiple REMS programs, corresponding to the TIRF product they choose to prescribe or dispense.  The new shared REMS – modeled after the program created for ABSTRAL - will go live in March 2012; at that time, prescribers, pharmacies, patients, and distributors may all be enrolled in a single program for these products. All stakeholders currently enrolled
'/>"/>

SOURCE ProStrakan, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 6, 2015  LumiThera Inc., a medical device ... treatment for ocular disorders and disease, today announced Retired ... LumiThera,s Advisory Board to assist in the company,s mission ... "Norm" Dicks was the U.S. Representative for ... and 2013. He is a member of the Democratic ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Global Insulin Patch Market Opportunity ... Highly advanced technology like ultrasound and iontophoresis are ... patches. Depending upon the type of technique, their ... reach of several patients. In long-term, it would ...
(Date:5/6/2015)... May 6, 2015   CEFALY Technology , the ... device specifically authorized for use prior to the onset ... in migraine treatment at the EUROHEADPAIN - Midterm Meeting ... Valencia, Spain , from May 14-17, 2015. ... of EUROHEADPAIN, a major European research project focused on ...
Breaking Medicine Technology:Retired Congressman Norman Dicks Joins LumiThera's Advisory Team 2Global Insulin Patch Market Opportunity Analysis 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2
... KONG, Dec. 22 /PRNewswire-Asia/ -- A young Olympic champion,volunteered to ... On Dec. 20, 2009, Xiong Ni became the first health ... an honor,to have him promote the application of endoscopic diagnostic ... "Endoscopic medicine is closely related to sports. More ...
... , , RICHMOND, Virginia and ROSH ... innovative solutions for advanced,chronic wound management, announced today that it ... The round was led by Eli Gilboa,CPA, of Gilboa & ... valuation of US$18.5 million. To date, the company has raised ...
Cached Medicine Technology:Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World 2Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World 3EnzySurge, Maker of DermaStream(R) Secures US$2.5 Million in Private Capital 2
(Date:5/6/2015)... May 06, 2015 Vancouver Chiropractic ... shared their new blog containing the Canadian Physical ... the Canadian Society for Exercise Physiology (CSEP). Since ... activity, health and fitness research and personal training ... exercise are highly beneficial and a rich resource ...
(Date:5/6/2015)... Healthcare jobs platform, JobMedic.com, ... in mid-February. The company connects hospitals, home-health, and other ... in the industry. Likewise, job seekers are able to ... Johnson, CTO, unique traffic to the site is up ... new job posting brings targeted, interested candidates to the ...
(Date:5/6/2015)... The 2015 STEMtech conference exhibition hall floor plan ... selection . Don’t miss this opportunity to highlight your ... decision-makers from around the country. , This year’s event ... Grand in Phoenix. This beautiful all-suite hotel is nestled ... the South Mountain Preserve. The Phoenix area offers southwestern ...
(Date:5/6/2015)... Topical BioMedics, Inc., announces its May Pain ... 12pm – 1pm, streamed live and then archived and accessible ... the public by clicking on the following link: ... “real time” during the webinar, and questions may also be ... The topic for the May webinar is “What You need ...
(Date:5/6/2015)... Cloud security companies Sookasa Inc ... partnership to help small-to-medium businesses secure their sensitive data ... are teaming up to transition SafeMonk customers to Sookasa’s ... to welcome SafeMonk users to the Sookasa family, and ... SafeMonk, the global powerhouse SafeNet (now Gemalto IDSS), are ...
Breaking Medicine News(10 mins):Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 2Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 3Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 4Health News:Topical BioMedics Hosts May Pain Management Webinar “What You need to Know about Fibromyalgia” 5Health News:Sookasa Grows Globally With SafeMonk Partnership 2Health News:Sookasa Grows Globally With SafeMonk Partnership 3
... Concerns Include Possible ... Dengue and Cholera Outbreaks, NEW YORK, Nov. 2 ... disasters in the history of the country,officials with the United Nations ... those affected by the recent floods,in the Mexican state of Tabasco ...
... 2 The College of Optometrists in Vision,Development ... L.,Fortenbacher, O.D., FCOVD, was installed as its 29th ... Annual Meeting held on,October 20. Dr. Fortenbacher, 53, ... of,Directors for eight years, assumes the new role ...
... Westaim Corporation,announced today the receipt of an offer, subject ... from a major financial institution. The,credit facility will be ... the,equivalent value of asset-backed commercial paper (ABCP) held by ... million in ABCP. In,September, the Company realized proceeds of ...
... XTENT, Inc.,(Nasdaq: XTNT ) today reported financial results ... reported a net loss of $9.5 million, or $0.42 per ... loss of $8.0 million, or,$2.84 per share, for the same ... third quarter of 2007 was based on weighted average shares,outstanding ...
... to Raise One Million Inches of Hair to Help ... Provide Free Wigs for Women with Cancer, CINCINNATI, ... Pantene Beautiful Lengths in a powerful,declaration of support for women with ... strength by giving their,healthy hair to create free wigs for women ...
... future, national litigation., BOSTON, Nov. 2 Today ... in damages against drug giants,AstraZeneca (NYSE: AZN ) ... role in unfair trade practices involving the pricing of ... implications in future,litigation. On June 21, 2007, Judge ...
Cached Medicine News:Health News:UNICEF Readies to Assist Mexican Flood Victims 2Health News:UNICEF Readies to Assist Mexican Flood Victims 3Health News:Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of 'College of Optometrists in Vision Development' (COVD); Unveils 7-Part Development Plan for Ongoing Growth 2Health News:Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of 'College of Optometrists in Vision Development' (COVD); Unveils 7-Part Development Plan for Ongoing Growth 3Health News:The Westaim Corporation update on status of short-term investments 2Health News:XTENT Announces Third Quarter 2007 Financial Results 2Health News:XTENT Announces Third Quarter 2007 Financial Results 3Health News:XTENT Announces Third Quarter 2007 Financial Results 4Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 2Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 3Health News:Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM) 4Health News:Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case 2Health News:Hagens Berman Sobol Shapiro: Judge Orders Double Damages, Issues Stinging Rebuke in Average Wholesale Price Case 3
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 0.2-2 Inaccuracy (%) ... Imprecision(%) ... 0.01 Dimensions: ...
... the range from 2ul to 5000ul. Fills ... design prevents inadvertent volume change. Novel hand ... pipette is autoclavable at 121C(250F). To prevent ... Suitable for one-handed operation. Auto or Normal ...
... adjustable, air-displacement pipette with a patented multifunctional ... of the Pipetman family, sharing many of ... We also added a number of features ... models cover the full range of volumes ...
Medicine Products: